US 10335365
Bladder cancer specific ligand peptides
granted A61KA61K38/00A61K47/51
Quick answer
US patent 10335365 (Bladder cancer specific ligand peptides) held by The United States of America as represented by the Department of Veteran Affairs (Washington DC) expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Department of Veteran Affairs (Washington DC)
- Grant date
- Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K38/00, A61K47/51, A61K47/64, A61K47/66